Discussion.

Epilepsia

Published: November 1997

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1528-1157.1997.tb06116.xDOI Listing

Publication Analysis

Top Keywords

discussion
4
discussion
1

Similar Publications

Introduction: Few data on the impact of specific interventions against Emergency Rooms 'or Hospitals overcrowding are available in France.

Methods: In the present report, we retrospectively investigated the impact of the implementation of a short-stay observation unit associated with the admitter-rounder model, especially onto the other in-patient internal medicine units in a French University Hospital.

Results: During the first 100 days, 242 patients were admitted into the short-stay observation unit.

View Article and Find Full Text PDF

Factorial Clinical Trial Designs.

JAMA

January 2025

Department of Preventive Medicine-Biostatistics and Informatics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article and Find Full Text PDF

Speech Technology for Automatic Recognition and Assessment of Dysarthric Speech: An Overview.

J Speech Lang Hear Res

January 2025

Centre for Language Studies, Radboud University, Nijmegen, the Netherlands.

Purpose: In this review article, we present an extensive overview of recent developments in the area of dysarthric speech research. One of the key objectives of speech technology research is to improve the quality of life of its users, as evidenced by the focus of current research trends on creating inclusive conversational interfaces that cater to pathological speech, out of which dysarthric speech is an important example. Applications of speech technology research for dysarthric speech demand a clear understanding of the acoustics of dysarthric speech as well as of speech technologies, including machine learning and deep neural networks for speech processing.

View Article and Find Full Text PDF

Purpose Of Review: The 2024 mpox outbreak, primarily driven by the possibly more virulent clade Ib strain, prompted the WHO declaring it a public health emergency of international concern (PHEIC) on August 14, 2024. This review provides essential guidance for clinicians managing mpox cases, as it contrasts the features of the 2024 outbreak with those of the 2022 epidemic to support better clinical decision-making.

Recent Findings: The review highlights significant differences between the 2024 and 2022 outbreaks, including total case numbers, demographic distribution, and fatality rates.

View Article and Find Full Text PDF

Cannabinoid-based Pharmacology for the Management of Substance Use Disorders.

Curr Top Behav Neurosci

January 2025

Department of Neurobiology, University of Maryland, School of Medicine, Baltimore, MD, USA.

In the last two decades, the endocannabinoid system has emerged as a crucial modulator of motivation and emotional processing. Due to its widespread neuroanatomical distribution and characteristic retrograde signaling nature, cannabinoid type I receptors and their endogenous ligands finely orchestrate somatic and axon terminal activity of dopamine neurons. Owing to these unique features, this signaling system is a promising pharmacological target to ameliorate dopamine-mediated drug-seeking behaviors while circumventing the adverse side effects of, for instance, dopaminergic antagonists.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!